← FDA Drug Approvals (Drugs@FDA)
METAXALONE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2017-08-31
Drug application
- FDA Application #
ANDA207466- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- METAXALONE
- Generic name
- METAXALONE
- Active ingredients
- METAXALONE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- SCIEGEN PHARMS
- Manufacturer
- BluePoint Laboratories
- First approval
- 2017-08-31
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown